Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ruth-Miriam Körber"'
Autor:
Frank Stegelmann, Lino L. Teichmann, Florian H. Heidel, Carl C. Crodel, Thomas Ernst, Sebastian Kreil, Andreas Reiter, Sara Otten, Stefanie Schauer, Ruth-Miriam Körber, Kim Kricheldorf, Susanne Isfort, Hartmut Döhner, Tim H. Brümmendorf, Martin Griesshammer, Konstanze Döhner, Steffen Koschmieder
Publikováno v:
Leukemia. 37:924-928
Autor:
Frank Stegelmann, Lino L. Teichmann, Florian H. Heidel, Carl C. Crodel, Thomas Ernst, Sebastian Kreil, Andreas Reiter, Sara Otten, Stefanie Schauer, Ruth-Miriam Körber, Kim Kricheldorf, Susanne Isfort, Hartmut Döhner, Tim H. Brümmendorf, Martin Griesshammer, Konstanze Döhner, Steffen Koschmieder
Publikováno v:
Blood. 140:6874-6876
Autor:
Steffen Koschmieder, Gabor Horvath, Ines Gütgemann, Andreas Buness, Ruth-Miriam Körber, Lino L. Teichmann, Rebekka K. Schneider, David C A Molitor, Peter Boor
Publikováno v:
Annals of Hematology
Annals of Hematology, 100(1), 97-104. Springer-Verlag
Annals of hematology 100(1), 97-104 (2021). doi:10.1007/s00277-020-04304-Y
Annals of Hematology, 100(1), 97-104. Springer-Verlag
Annals of hematology 100(1), 97-104 (2021). doi:10.1007/s00277-020-04304-Y
Annals of hematology 100(1), 97-104 (2021). doi:10.1007/s00277-020-04304-Y
Published by Springer, Berlin ; Heidelberg ; New York
Published by Springer, Berlin ; Heidelberg ; New York
Interferon Gamma (IFNγ) Interferes with the Effects of Tyrosine Kinase Inhibitors (TKI) In CML Cells
Autor:
Grethe Kock, Nina Manon Seltmann, Stefanie Ae Held, Peter Brossart, Anita Bringmann, Ruth-Miriam Körber, Annkristin Heine
Publikováno v:
Blood. 116:3393-3393
Abstract 3393 Introduction: Chronic myeloid leukemia (CML) is a myeloproliferative disease which resolves in the constitutive activity of the BCR-ABL protein. Since the introduction of imatinib as first line therapy for CML, the overall survival of p
Autor:
Peter Brossart, Anita Bringmann, Marie von Lilienfeld-Toal, Stefanie Ae Held, Ruth-Miriam Körber, Solveig Nora Daecke
Publikováno v:
Blood. 116:4071-4071
Abstract 4071 Introduction: Multiple myeloma (MM) is a malignant plasma cell disorder characterized by clonal expansion of single plasma cells in the bone marrow. Despite high-dose melphalan therapy with autologous stem cell transplantation (ASCT) an